COGT
Cogent Biosciences Inc
NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY
$35.87
-1.29% today
Updated 2026-04-29
Market cap
$6.29B
P/E ratio
—
P/S ratio
861.15x
EPS (TTM)
$-2.16
Dividend yield
—
52W range
$5 – $44
Volume
2.1M
Cogent Biosciences Inc (COGT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $94.77M | $75.55M | $49.12M | $85.93M | $49.42M | $250.92M | $232.09M | $300.81M | $313.44M | $327.90M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — |
| Current assets | $91.10M | $69.73M | $42.38M | $81.00M | $40.59M | $244.91M | $222.63M | $264.97M | $270.77M | $296.47M |
| Total liabilities | $25.25M | $23.16M | $20.81M | $25.69M | $17.66M | $16.25M | $17.91M | $45.08M | $55.63M | $71.61M |
| Current liabilities | $7.29M | $8.74M | $11.19M | $24.95M | $13.25M | $13.09M | $17.08M | $26.85M | $38.17M | $55.71M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-7.72M | $-25.85M | $-51.34M | $-92.06M | $-123.89M | $-198.70M | $-270.97M | $-411.21M | $-603.62M | $-859.48M |
| Accounts receivable | $294000.00 | $928000.00 | $830000.00 | $1.67M | $2.00M | $0.00 | — | — | — | — |
| Inventory | — | — | $75000.00 | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — |